BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35047353)

  • 1. Heparanase-1 is downregulated in chemoradiotherapy orbital rhabdomyosarcoma and relates with tumor growth as well as angiogenesis.
    Tang WQ; Hei Y; Lin J
    Int J Ophthalmol; 2022; 15(1):31-39. PubMed ID: 35047353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparanase activity in alveolar and embryonal rhabdomyosarcoma: implications for tumor invasion.
    Masola V; Maran C; Tassone E; Zin A; Rosolen A; Onisto M
    BMC Cancer; 2009 Aug; 9():304. PubMed ID: 19715595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of heparanase in high-glucose-treated endothelial cells promotes endothelial cell migration and proliferation and correlates with Akt and extracellular-signal-regulated kinase phosphorylation.
    Yuan L; Hu J; Luo Y; Liu Q; Li T; Parish CR; Freeman C; Zhu X; Ma W; Hu X; Yu H; Tang S
    Mol Vis; 2012; 18():1684-95. PubMed ID: 22773906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparanase-1 and components of the hedgehog signalling pathway are increased in untreated alveolar orbital rhabdomyosarcoma.
    Tang WQ; Hei Y; Kang L; Xiao LH
    Clin Exp Ophthalmol; 2014 Mar; 42(2):182-9. PubMed ID: 23777428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Heparanase promotes trans-endothelial migration of hepatocarcinoma cells by inducing apoptosis of microvascular endothelial cells].
    Chen X; Ye R; Dai D; Wu Y; Yu Y; Cheng B
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Aug; 40(8):1065-1071. PubMed ID: 32895190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor 2 mRNA binding protein 2 regulates proliferation, migration, and angiogenesis of keratinocytes by modulating heparanase stability.
    Zhi S; Li J; Kong X; Xie X; Zhang Q; Fang G
    Bioengineered; 2021 Dec; 12(2):11267-11276. PubMed ID: 34753397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparanase regulates
    Lv B; Zhang B; Hu XY; Zeng QD
    Oncol Lett; 2016 Feb; 11(2):1327-1334. PubMed ID: 26893739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS.
    Ciarapica R; Carcarino E; Adesso L; De Salvo M; Bracaglia G; Leoncini PP; Dall'agnese A; Verginelli F; Milano GM; Boldrini R; Inserra A; Stifani S; Screpanti I; Marquez VE; Valente S; Mai A; Puri PL; Locatelli F; Palacios D; Rota R
    BMC Cancer; 2014 Feb; 14():139. PubMed ID: 24575771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-429 decreases the invasion ability of gastric cancer cell line BGC-823 by downregulating the expression of heparanase.
    Sheng N; Zhang L; Yang S
    Exp Ther Med; 2018 Feb; 15(2):1927-1933. PubMed ID: 29434786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Antitumor Efficacy of RNAi-Mediated Inhibition of CDC20 and Heparanase in an Orthotopic Liver Tumor Model.
    Liu M; Zhang Y; Liao Y; Chen Y; Pan Y; Tian H; Zhan Y; Liu D
    Cancer Biother Radiopharm; 2015 Aug; 30(6):233-9. PubMed ID: 26132704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXM1 expression in rhabdomyosarcoma: a novel prognostic factor and therapeutic target.
    Kuda M; Kohashi K; Yamada Y; Maekawa A; Kinoshita Y; Nakatsura T; Iwamoto Y; Taguchi T; Oda Y
    Tumour Biol; 2016 Apr; 37(4):5213-23. PubMed ID: 26553361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The expression and significance of heparanase in oral squamous cell carcinoma with different metastatic potentials].
    Wu XB; Wang RY; Gong ZJ; Yu J; Zhu SR
    Zhonghua Yi Xue Za Zhi; 2016 Oct; 96(38):3047-3052. PubMed ID: 27784443
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of adipose-derived stem cell released exosomes on proliferation, migration, and tube-like differentiation of human umbilical vein endothelial cells].
    Zhang J; Yi Y; Yang S; Zhu Y; Hu X
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2018 Oct; 32(10):1351-1357. PubMed ID: 30600670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin‑17A and heparanase promote angiogenesis and cell proliferation and invasion in cervical cancer.
    Lv Q; Wu K; Liu F; Wu W; Chen Y; Zhang W
    Int J Oncol; 2018 Oct; 53(4):1809-1817. PubMed ID: 30066843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentiviral miR30-based RNA interference against heparanase suppresses melanoma metastasis with lower liver and lung toxicity.
    Liu XY; Tang QS; Chen HC; Jiang XL; Fang H
    Int J Biol Sci; 2013; 9(6):564-77. PubMed ID: 23847439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoradiotherapy Increases Intratumor Heterogeneity of HPSE Expression in the Relapsed Glioblastoma Tumors.
    Suhovskih AV; Kazanskaya GM; Volkov AM; Tsidulko AY; Aidagulova SV; Grigorieva EV
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-219a-2-3p modulates the proliferation of thyroid cancer cells via the HPSE/cyclin D1 pathway.
    Yang C; Zhang S; Chang X; Huang Y; Cui D; Liu Z
    Exp Ther Med; 2021 Jun; 21(6):659. PubMed ID: 33968189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of heparanase in osteogenic differentiation of rat marrow stromal cells.
    Han Q; Liu F; Zhou Y
    Exp Ther Med; 2013 Jun; 5(6):1697-1700. PubMed ID: 23837057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines.
    Onisto M; Slongo ML; Gregnanin L; Gastaldi T; Carli M; Rosolen A
    Int J Oncol; 2005 Sep; 27(3):791-8. PubMed ID: 16077930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-126 inhibits tube formation of HUVECs by interacting with EGFL7 and down-regulating PI3K/AKT signaling pathway.
    Li Q; Cheng K; Wang AY; Xu QG; Fu ZF; He SY; Xu PX
    Biomed Pharmacother; 2019 Aug; 116():109007. PubMed ID: 31170663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.